← Leaderboards
Patricia Manuela Ribeiro Pereira
Washington University
$2,069,397
Attributed
$2,269,311
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
NIH$2,269,311 · 2
By mechanism
R37$1,869,482 · 1
R21$399,829 · 1
Top collaborators
- Zhude Tu1 shared
Most similar at Washington University
Same institution · by research overlap
- Jason C Mills$17,130,215
- Jose Bernardo Saenz$1,871,701
- Shrikant Anant$8,735,951
- Zhude Tu$14,617,536
- Matthew J Walter$8,261,626
Others in their field
Other Rising Stars on “Malignant Stomach Neoplasm”
- Linghua Wang · University Of Tx Md Anderson Can Ctr$2,551,693
- Jesse Mischa McFarland · Shasqi, Inc.$2,546,903
- Tae Hyun Hwang · Ut Southwestern Medical Center$1,961,240
- Maria Pia Morelli · University Of Tx Md Anderson Can Ctr$1,662,703
- Stanton Bradley Gray · University Of Tx Md Anderson Can Ctr$1,360,793
- Silas Maniatis · Columbia University Health Sciences$1,360,019
Research focus
Malignant Stomach NeoplasmPathway InteractionsImageMalignant NeoplasmsMolecular ImagingMutationFoundationsGastric Cancer CellInvestigationMalignant Breast NeoplasmMembraneAntibodiesBindingMonitorDrug ResistanceErbb2 GeneFutureClassificationAntibody-Drug ConjugatesImaging StudyClinical TranslationLabelAntibody TherapyPatient Derived Xenograft Model
Grant awards (4)
Reversing Drug Resistance in Tumors with Clickable Antibody Pairs$633,658
R37 · FY2025 · CA · contact PI
Reversing Drug Resistance in Tumors with Clickable Antibody Pairs$601,992
R37 · FY2024 · CA · contact PI
S1PR1-targeted PET imaging to predict and monitor response to HER2-targeting antibody-drug conjugates$399,829
R21 · FY2024 · CA · contact PI
Reversing Drug Resistance in Tumors with Clickable Antibody Pairs$633,832
R37 · FY2023 · CA · contact PI